-
1
-
-
84944049079
-
-
Eds.; Elsevier Science Oxford Chap. 9.06
-
Tucker H, LeCount D J., In Comprehensive Heterocyclic Chemistry II Vol. 9 Rees C W., Katritzky A R., Scriven E F. V., Elsevier Science Oxford 1996 Chap. 9.06 151-182
-
(1996)
Comprehensive Heterocyclic Chemistry II
, vol.9
, pp. 151-182
-
-
Tucker, H.1
Lecount, D.J.2
Rees, C.W.3
Katritzky, A.R.4
Scriven, E.F.V.5
Rees, C.W.6
Katritzky, A.R.7
Scriven, E.F.V.8
-
3
-
-
0029942348
-
-
Artico M, Silvestri R, Pagnozzi E, Stefancich G, Massa S, Loi A G., Putzolu M, Corrias S, Spiga M G., LaColla P, Bioorg. Med. Chem. 1996 4 837
-
(1996)
Bioorg. Med. Chem.
, vol.4
, pp. 837
-
-
Artico, M.1
Silvestri, R.2
Pagnozzi, E.3
Stefancich, G.4
Massa, S.5
Loi, A.G.6
Putzolu, M.7
Corrias, S.8
Spiga, M.G.9
Lacolla, P.10
-
4
-
-
0031954544
-
-
Costi R, DiSanto R, Artico M, Massa S, Marongiu [nl]M E., Loi A G., DeMontis A, LaColla P, Antiviral Chem. Chemother. 1998 9 127
-
(1998)
Antiviral Chem. Chemother.
, vol.9
, pp. 127
-
-
Costi, R.1
Disanto, R.2
Artico, M.3
Massa, S.4
Marongiu, M.E.5
Loi, A.G.6
Demontis, A.7
Lacolla, P.8
-
5
-
-
0029073491
-
-
Giannotti D, Viti G, Nannicini R, Pestellini V, Bellarosa D, Bioorg. Med. Chem. Lett. 1995 5 1461
-
(1995)
Bioorg. Med. Chem. Lett.
, vol.5
, pp. 1461
-
-
Giannotti, D.1
Viti, G.2
Nannicini, R.3
Pestellini, V.4
Bellarosa, D.5
Costi, R.6
Disanto, R.7
Artico, M.8
Massa, S.9
Langlois, N.10
Andriamialisoa, R.Z.11
-
6
-
-
0036185075
-
-
Costi R, DiSanto R, Artico M, Massa S, [nl] J. Heterocycl. Chem. 2002 39 81
-
(2002)
J. Heterocycl. Chem.
, vol.39
, pp. 81
-
-
Costi, R.1
Disanto, R.2
Artico, M.3
Massa, S.4
-
8
-
-
0012727923
-
-
Cherney R J., Duan J J.-W, Voss M E., Chen L, Wang L, Meyer D T., Wasserman Z R., Hardman K D., Liu R.-Q, Covington M B., Qian M, Mandlekar S, Christ [nl]D D., Trzaskos J M., Magolda R L., Wexler R R., Decicco C P., J. Med. Chem. 2003 46 1811
-
(2003)
J. Med. Chem.
, vol.46
, pp. 1811
-
-
Cherney, R.J.1
Duan, J.J.-W.2
Voss, M.E.3
Chen, L.4
Wang, L.5
Meyer, D.T.6
Wasserman, Z.R.7
Hardman, K.D.8
Liu, R.-Q.9
Covington, M.B.10
Qian, M.11
Mandlekar, S.12
Christ, D.D.13
Trzaskos, J.M.14
Magolda, R.L.15
Wexler, R.R.16
Decicco, C.P.17
-
10
-
-
3543044968
-
-
Wilkinson G P., Taylor J P., Shnyder S, Cooper P, Howard P W., Thurston D E., Jenkins T C., Loadman [nl]P M., Invest. New Drugs 2004 22 231
-
(2004)
Invest. New Drugs
, vol.22
, pp. 231
-
-
Wilkinson, G.P.1
Taylor, J.P.2
Shnyder, S.3
Cooper, P.4
Howard, P.W.5
Thurston, D.E.6
Jenkins, T.C.7
Loadman, P.M.8
-
11
-
-
0034676683
-
-
Anwar B, Grimsey P, Hemming K, Krajniewski M, Loukou C, Tetrahedron Lett. 2000 51 10107
-
Tetrahedron Lett.
, vol.51
, pp. 10107
-
-
Anwar, B.1
Grimsey, P.2
Hemming, K.3
Krajniewski, M.4
Loukou, C.5
Hemming, K.6
Loukou, C.7
Loukou, C.8
Patel, N.9
Foucher, V.10
Hemming, K.11
-
13
-
-
31544466243
-
-
Loukou C, Patel N, Foucher V, Hemming K, [nl] J. Sulfur Chem. 2005 26 455
-
(2005)
J. Sulfur Chem.
, vol.26
, pp. 455
-
-
Loukou, C.1
Patel, N.2
Foucher, V.3
Hemming, K.4
-
16
-
-
0000300601
-
-
Bussas R, Kresze G, Münsterer H, Schwöbel A, Sulfur Rep. 1983 2 215
-
(1983)
Sulfur Rep.
, vol.2
, pp. 215
-
-
Bussas, R.1
Kresze, G.2
Münsterer, H.3
Schwöbel, A.4
-
17
-
-
0034742945
-
-
Jones A D., Hibbs D E., Knight D W., J. Chem. Soc., Perkin Trans. 1 2001 1182
-
(2001)
J. Chem. Soc., Perkin Trans. 1
, vol.47
, pp. 1182
-
-
Jones, A.D.1
Hibbs, D.E.2
Knight, D.W.3
-
22
-
-
0032575241
-
-
Hodgkinson T J., Kelland L R., Shipman M, Vile J, Tetrahedron 1998 54 6029
-
(1998)
Tetrahedron
, vol.54
, pp. 6029
-
-
Hodgkinson, T.J.1
Kelland, L.R.2
Shipman, M.3
Vile, J.4
-
24
-
-
24044531286
-
-
Bräse S, Gil C, Knepper K, Zimmermann V, Angew. Chem. Int. Ed. 2005 44 5188
-
(2005)
Angew. Chem. Int. Ed.
, vol.44
, pp. 5188
-
-
Bräse, S.1
Gil, C.2
Knepper, K.3
Zimmermann, V.4
-
29
-
-
0034741380
-
-
Garanti L, Molteni G, Broggini G, J. Chem. Soc., Perkin Trans. 1 2001 1816
-
(2001)
J. Chem. Soc., Perkin Trans. 1
, vol.15
, pp. 1816
-
-
Garanti, L.1
Molteni, G.2
Broggini, G.3
-
30
-
-
1042298820
-
-
Becalli E, Broggini G, Paladino G, Pilati T, Pontremoli G, Tetrahedron: Asymmetry 2004 15 687
-
(2004)
Tetrahedron: Asymmetry
, vol.15
, pp. 687
-
-
Becalli, E.1
Broggini, G.2
Paladino, G.3
Pilati, T.4
Pontremoli, G.5
-
31
-
-
0033579634
-
-
Broggini G, Molteni G, Terraneo A, Zecchi G, Tetrahedron 1999 55 14803
-
(1999)
Tetrahedron
, vol.55
, pp. 14803
-
-
Broggini, G.1
Molteni, G.2
Terraneo, A.3
Zecchi, G.4
-
33
-
-
72049127967
-
-
PhD Thesis, For full details (including X-ray crystallographic data), see: University of Huddersfield UK 2006
-
For full details (including X-ray crystallographic data), see:, NileshPatel, PhD Thesis University of Huddersfield UK 2006
-
-
-
Patel, N.1
-
34
-
-
38349162569
-
-
Corres N, Delgado J J., García-ValverdeMracaccini S, Rodríguez T, Rojo J, Torroba T, Tetrahedron 2008 64 2225
-
(2008)
Tetrahedron
, vol.64
, pp. 2225
-
-
Corres, N.1
Delgado, J.J.2
García-Valverdemracaccini, S.3
Rodríguez, T.4
Rojo, J.5
Torroba, T.6
-
35
-
-
0034142299
-
-
Bremner J B., Russell H F., Skelton B W., White A H., Heterocycles 2000 53 277
-
(2000)
Heterocycles
, vol.53
, pp. 277
-
-
Bremner, J.B.1
Russell, H.F.2
Skelton, B.W.3
White, A.H.4
-
39
-
-
0029101546
-
-
Herold P, Herzig J W., Wenk P, Leutert T, Zbinden P, Fuhrer W, Stutz S, Schenker K, Meier M, Rihs G, [nl] J. Med. Chem. 1995 38 2946
-
(1995)
J. Med. Chem.
, vol.38
, pp. 2946
-
-
Herold, P.1
Herzig, J.W.2
Wenk, P.3
Leutert, T.4
Zbinden, P.5
Fuhrer, W.6
Stutz, S.7
Schenker, K.8
Meier, M.9
Rihs, G.10
-
40
-
-
2742517067
-
-
DiSanto R, Costi R, Artico M, Massa S, J. Heterocycl. Chem. 1996 33 2019
-
(1996)
J. Heterocycl. Chem.
, vol.33
, pp. 2019
-
-
Disanto, R.1
Costi, R.2
Artico, M.3
Massa, S.4
-
43
-
-
0347625762
-
-
Vedejs E, Naidu B N., Klapars A, Warner [nl]D L., Li V S., Na Y, Kohn H, J. Am. Chem. Soc. 2003 125 15796
-
(2003)
J. Am. Chem. Soc.
, vol.125
, pp. 15796
-
-
Vedejs, E.1
Naidu, B.N.2
Klapars, A.3
Warner, D.L.4
Li, V.S.5
Na, Y.6
Kohn, H.7
-
44
-
-
38949121259
-
-
Zhou Y F., Webber S E., Murphy D E., Li L S., Dragovich P S., Tran C V., Sun Z X., Ruebsam F, Shah A M., Tsan M, Showalter R E., Patel R, Li B, Zhoa Q, Han Q, Hermann T, Kissinger C R., LeBrun L, Sergeeva M V., Kirkovsky L, Bioorg. Med. Chem. Lett. 2008 18 1413
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 1413
-
-
Zhou, Y.F.1
Webber, S.E.2
Murphy, D.E.3
Li, L.S.4
Dragovich, P.S.5
Tran, C.V.6
Sun, Z.X.7
Ruebsam, F.8
Shah, A.M.9
Tsan, M.10
Showalter, R.E.11
Patel, R.12
Li, B.13
Zhoa, Q.14
Han, Q.15
Hermann, T.16
Kissinger, C.R.17
Lebrun, L.18
Sergeeva, M.V.19
Kirkovsky, L.20
more..
-
45
-
-
34347213071
-
-
Francotte P, deTullio P, Goffin E, Dintilhac G, Graindorge E, Fraikin P, Lestage P, Danober L, Thomas J.-Y, Ciagnard D.-H, Piroote B, J. Med. Chem. 2007 50 3153
-
(2007)
J. Med. Chem.
, vol.50
, pp. 3153
-
-
Francotte, P.1
Detullio, P.2
Goffin, E.3
Dintilhac, G.4
Graindorge, E.5
Fraikin, P.6
Lestage, P.7
Danober, L.8
Thomas, J.-Y.9
Ciagnard, D.-H.10
Piroote, B.11
-
46
-
-
20844445619
-
-
Boverie S, Antoine M H., Somers F, Becker B, Sebille S, Ouedraogo R, Counerotte S, Pirotte B, Lebrun P, deTullio P, J. Med. Chem. 2005 48 3492
-
(2005)
J. Med. Chem.
, vol.48
, pp. 3492
-
-
Boverie, S.1
Antoine, M.H.2
Somers, F.3
Becker, B.4
Sebille, S.5
Ouedraogo, R.6
Counerotte, S.7
Pirotte, B.8
Lebrun, P.9
Detullio, P.10
-
47
-
-
23944453990
-
-
Broggini G, DeMarchi I, Martinelli M, Paladino G, Pilati T, Terraneo A, Synthesis 2005 2246
-
(2005)
Synthesis
, vol.1
, pp. 2246
-
-
Broggini, G.1
Demarchi, I.2
Martinelli, M.3
Paladino, G.4
Pilati, T.5
Terraneo, A.6
-
48
-
-
33645489520
-
-
Broggini G, DeMarchi I, Martinelli M, Paladino G, Pennoni A, Lett. Org. Chem. 2004 1 221
-
(2004)
Lett. Org. Chem.
, vol.1
, pp. 221
-
-
Broggini, G.1
Demarchi, I.2
Martinelli, M.3
Paladino, G.4
Pennoni, A.5
-
49
-
-
0035906066
-
-
Santagada V, Perissutti E, Fiorino F, Vivenzio B, Caliendo G, Tetrahedron Lett. 2001 42 2397
-
(2001)
Tetrahedron Lett.
, vol.42
, pp. 2397
-
-
Santagada, V.1
Perissutti, E.2
Fiorino, F.3
Vivenzio, B.4
Caliendo, G.5
-
50
-
-
72049120592
-
-
note
-
Typical Procedure for the Synthesis of Compounds 8a-c To a stirred solution of the homoallylic 2-aminobenzenesulfonamide 6a-c (0.15-0.30 g, 1.0 equiv) and NaHCO3 (3.0 equiv) i n dry MeCN (10 mL) was added portionwise finely powdered iodine (3.0 equiv). The reaction mixture was stirred at r.t. until TLC showed no starting material (ca. 4 h) at which point the reaction mixture was treated with sat. aq Na2S2O3 until decolourisation occurred. The resulting solution was extracted with CH2Cl2 (3 ×20 mL), and the combined organic extracts dried (MgSO4), filtered, and concentrated by rotary evaporation. The crude product was purified by gravity column chromatography (SiO2) using PE-EtOAc (3:2) as the eluent. Compound 8a was obtained single spot pure [Rf = 0.3 (PE-EtOAc, 2:3)] as a yellow oil (0.161 g, 49% yield) from the N-(butenyl)-2-aminobenzenesulfonamide (6a, 0.320 g).
-
-
-
-
51
-
-
72049104709
-
-
note
-
Typical Procedure for the Synthesis of Compounds 8a-c To a stirred solution of the homoallylic 2-aminobenzenesulfonamide 6a-c (0.15-0.30 g, 1.0 equiv) and NaHCO3 (3.0 equiv) i n dry MeCN (10 mL) was added portionwise finely powdered iodine (3.0 equiv). The reaction mixture was stirred at r.t. until TLC showed no starting material (ca. 4 h) at which point the reaction mixture was treated with sat. aq Na2S2O3 until decolourisation occurred. The resulting solution was extracted with CH2Cl2 (3 ×20 mL), and the combined organic extracts dried (MgSO4), filtered, and concentrated by rotary evaporation. The crude product was purified by gravity column chromatography (SiO2) using PE-EtOAc (3:2) as the eluent. Compound 8a was obtained single spot pure [Rf = 0.3 (PE-EtOAc, 2:3)] as a yellow oil (0.161 g, 49% yield) from the N-(butenyl)-2- aminobenzenesulfonamide (6a, 0.320 g). Analytical Data 1H NMR (400 MHz, CDCl3): d = 1.35 (3 H, s, Me), 1.51 (1 H, dd, J = 11.2, 8.4 Hz, CMeCH2CH2NH), 2.02 (1 H, ddd, J = 8.4, 5.9, 2.5 Hz, CMeCH2CH2NH), 2.11 (1 H, s, aziridino CH), 2.33 (1 H, s, aziridino CH), 3.36 (1 H, m, CH2CH2NH), 3.79 (1 H, ddd, J = 15.0, 7.5, 6.1 Hz, CH2CH2NH), 5.32 (1 H, t, J = 6.1 Hz, SO2NH), 6.85 (1 H, d, J = 7.9 Hz, ArH), 6.98 (1 H, dt, J = 8.4, 0.8 Hz, ArH), 7.35 (1 H, dt, J = 8.4, 1.4 Hz, ArH), 7.83 (1 H, dd, J = 7.9, 1.3 Hz, ArH). 13C NMR (100 MHz, CDCl3): d = 20.2 (CH3), 35.8 (CH2), 39.2 (CH2), 40.2 (CH2), 43.9 (q), 121.7 (CH), 122.0 (CH), 128.6 (CH), 129.6 (q), 133.0 (CH), 147.8 (q). IR: nmax = 3101 (br m), 2953 (m), 2896 (m), 1591 (m), 1472 (s), 1439 (m), 1333 (s), 1216 (s), 1158 (s), 866 (m) cm-1. HRMS (ES+): m/z calcd for C11H14N2O2S: 239.0849; found: 239.0845 (100%) [M + H]+.
-
-
-
-
52
-
-
72049108845
-
-
note
-
Typical Procedure for the Synthesis of Compounds 11a-c A solution of the N-(butenyl)-2-azidobenzenesulfonamide 9a-c (ca. 100 mg) in DMF (5 mL) was heated at reflux temperature until TLC showed no starting material (2-3 h). The mixture was cooled, the solvent removed by reduced pressure rotary evaporation, and the residue purified by flash silica column chromatography (PE-EtOAc = 3:2). As an example, pyrrolo-1,2,4-benzothiadiazine 11b (76 mg, 45%) was obtained from azidobenzenesulfonamide 9b (130 mg). Analytical Data 1H NMR (400 MHz, CDCl3): d = 1.73 (3 H, s, CH3), 1.78 (3 H, d, J = 7.2 Hz, CH3), 1.88 (1 H, dd, J = 13.0, 10.2 Hz, CMeCHHCHMe), 2.21 (1 H, dd, J = 13.0, 7.1 Hz, CMeCHHCHMe), 2.41-2.48 (1 H, m, [(CH2)2CHMe], 3.23 (1 H, dd, J = 10.3, 7.0 Hz, NCHH), 3.58 (1 H, dd, J = 10.0, 7.0 Hz, NCHH), 4.56 (1 H, s, NH), 6.61 (1 H, d, J = 8.4 Hz, ArH), 6.76 (1 H, t, J = 8.0 Hz, ArH), 7.24 (1 H, td, J = 8.4, 1.3 Hz, ArH), 7.68 (1 H, dd, J = 8.0, 1.3 Hz, ArH). 13C NMR (100 MHz, CDCl3): d = 18.6 (CH3), 27.2 (CH3), 28.3 (CH), 51.0 (CH2), 57.9 (CH2), 79.8 (q), 115.3 (CH), 117.5 (CH), 129.3 (CH), 133.2 (CH), 142.3 (q), 145.0 (q). IR (thin film): nmax = 3366 (s), 2965 (s), 2932 (s), 1677 (m), 1605 (s), 1484 (s), 1453 (s), 1322 (s), 1157 (s), 751 (s) cm-1. HRMS (ES+): m/z calcd for C12H16N2O2S + H+: 253.1005; found: 253.1008 [M + H]+.
-
-
-
-
53
-
-
72049109620
-
-
note
-
Analytical Data for Compound 16 (X = CO, R1 = R2 = H) 1H NMR (400 MHz, CDCl3): d = 2.00 (1 H, d, J = 3.6 Hz, aziridine CH2), 2.04-2.16 (3H, m, CH2 + CHH), 2.18-2.26 (1 H, m, CHH), 2.53 (1 H, d, J = 4.3 Hz, aziridine CH2), 2.78 (1 H, ddd, J = 9.5, 4.3, 3.6 Hz, aziridine CH), 3.34 (1 H, ddd, J = 9.5, 2.9, 1.6 Hz, pyrrolidine CH), 3.62-3.69 (1 H, m, NCH2), 3.81-3.95 (1 H, m, NCH2), 7.01 (1 H, dt, J = 7.9, 0.7 Hz, ArH), 7.11 (1 H, d, J = 8.1 Hz, ArH), 7.44-7.52 (1 H, m, ArH), 7.74 (1 H, d, J = 7.9 Hz, ArH). 13C NMR (100 MHz, CDCl3): d = 23.1 (CH2), 29.4 (CH2), 32.7 (CH2), 44.8 (CH), 46.1 (CH2), 58.1 (CH), 122.0 (CH), 122.9 (CH), 126.8 (q), 129.7 (CH), 131.2 (CH), 145.6 (q), 150.3 (q). IR (thin film): nmax = 3063 (m), 2979 (m), 1625 (s), 1456 (s), 1405 (s), 1039 (m), 922 (m), 766 (s), 730 (s), 704 (s) cm-1. HRMS (ESI+): m/z calcd for C13H14N2O + H+: 215.1179; found: 215.1178 [M + H]+.
-
-
-
|